Ravindra Kothi (Ravi)

Ravindra Kothi, also known as Ravi, has over 26 years of experience in various roles within the pharmaceutical and healthcare industry. Ravindra started their career at Core Healthcare as a Product Executive, where they were involved in product management, market research, and the launch of medical equipment. Ravi then moved to Ranbaxy as a Business Manager, responsible for sales and marketing programs in Gujarat territory. Ravindra later joined Apollo Health Street as the Head of Apollo Breatheazy Clinics, where they established the Chest Disease Management Program and expanded the Medvarsity Educational Programs. Ravi then worked at Emcure Pharmaceuticals as a General Manager, focusing on international business development and handling the API business. Ravindra was responsible for various business development activities and the integration of Emcure's Canadian acquisition. Prior to their current role, Ravi was the Vice President of International Business Development at Centaur Pharmaceuticals, where they managed global API business and handled business development activities for regulated markets. Currently, Ravi is serving as the Vice President of International Business at Enaltec Labs Pvt Ltd.

Ravindra Kothi, also known as Ravi, completed their higher secondary education at Shreyas Vidyalaya from 1978 to 1989. It was during this period that they pursued their studies in the field of science. Following their higher secondary education, Ravi enrolled at M.S. University of Baroda from 1989 to 1995. During this time, they obtained a Master's degree in Applied Chemistry. Additionally, they pursued a Postgraduate Diploma in Business Management, further expanding their knowledge in the field. Ravi's education history reflects their academic endeavors in the fields of applied chemistry and business management.